UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Nature communications, 2018-03, Vol.9 (1), p.896-10, Article 896

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

The lancet oncology, 2010-03, Vol.11 (3), p.231-240

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Nature communications, 2023-07, Vol.14 (1), p.4017-4017, Article 4017

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study

Breast cancer research : BCR, 2022-09, Vol.24 (1), p.61-61, Article 61

2022

Link zum Volltext

Verfügbarkeit prüfen

Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer

Trials, 2022-05, Vol.23 (1), p.372-372, Article 372

2022

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA

Nature communications, 2021-07, Vol.12 (1), p.4479-4479, Article 4479

2021

Link zum Volltext

Verfügbarkeit prüfen

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design

Trials, 2021-06, Vol.22 (1), p.397-397, Article 397

2021

Link zum Volltext

Verfügbarkeit prüfen

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R46-R46, Article R46

2012

Link zum Volltext

Verfügbarkeit prüfen

Conducting non-commercial international clinical trials: the ICR-CTSU experience

Trials, 2017-09, Vol.18 (1), p.440-4, Article 440

2017

Link zum Volltext

Verfügbarkeit prüfen

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

NPJ breast cancer, 2021-02, Vol.7 (1), p.11-11, Article 11

2021

Link zum Volltext

Verfügbarkeit prüfen

In Regard to Vaidya et al

International journal of radiation oncology, biology, physics, 2015-08, Vol.92 (5), p.954-955

2015

Link zum Volltext

Verfügbarkeit prüfen

Implementation of platform trials in the COVID-19 pandemic: A rapid review

Contemporary clinical trials, 2022-01, Vol.112, p.106625-106625, Article 106625

2022

Link zum Volltext

Verfügbarkeit prüfen

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Radiotherapy and oncology, 2016-07, Vol.120 (1), p.114-118

2016

Link zum Volltext

Verfügbarkeit prüfen

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

Journal of clinical oncology, 2021-08, Vol.39 (24), p.2720-2731

2021

Link zum Volltext

Verfügbarkeit prüfen

TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)

European thyroid journal, 2017-07, Vol.6 (4), p.197-207

2017

Link zum Volltext

Verfügbarkeit prüfen

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037)

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920975352-1758835920975352

2020

Link zum Volltext

Verfügbarkeit prüfen

Accelerated partial breast irradiation: more questions than answers?

The Lancet (British edition), 2019-12, Vol.394 (10215), p.2127-2129

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Cancer discovery, 2021-11, Vol.11 (11), p.2796-2811

2021

Link zum Volltext

Verfügbarkeit prüfen

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4120-4129

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

Journal of clinical oncology, 2023-12, Vol.41 (35), p.5356

2023

Link zum Volltext

Verfügbarkeit prüfen

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies

Research involvement and engagement, 2018-07, Vol.4 (1), p.22-22, Article 22

2018

Link zum Volltext

Verfügbarkeit prüfen

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Clinical cancer research, 2022-04, Vol.28 (7), p.1323-1334

2022

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy for breast cancer, the TARGIT-A trial

The Lancet (British edition), 2014-05, Vol.383 (9930), p.1716-1717

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

ThemaAged

ThemaBreast Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(108)

Sprache

Englisch
(108)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study

Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

Conducting non-commercial international clinical trials: the ICR-CTSU experience

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

In Regard to Vaidya et al

Implementation of platform trials in the COVID-19 pandemic: A rapid review

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome: Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001)

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK – A16037)

Accelerated partial breast irradiation: more questions than answers?

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Radiotherapy for breast cancer, the TARGIT-A trial

Aktive Filter

Suchergebnisse filtern